Greater clinical benefit of more intensive oral anti-platelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38 - Wiviott, SD; Braunwald, E; Angiolillo, DJ (Circulation, 2008)
et al.